Related Experiment Video
Updated: Feb 28, 2026

Ileectomy-induced Bile Overaccumulation in Mouse Intestine
Published on: August 21, 2017
Extensive Colonic Pseudopolyposis Leading to Protein-Losing Enteropathy and Severe Hypoalbuminemia With Refractory
Huzaifa Nadeem1, Mohammad Alsaeid1, Alain Bitton1
1Division of Gastroenterology and Hepatology, McGill University Health Centre, Montreal, Quebec, Canada.
Abstract:
Extensive pseudopolyposis in ulcerative colitis (UC) is rare and can lead to protein-losing enteropathy (PLE) with severe hypoalbuminemia. We report an 18-year-old male with steroid-dependent UC complicated by extensive colonic pseudopolyposis causing PLE. This represents one of the few reported cases of PLE secondary to extensive colonic pseudopolyposis in UC. He presented with profound hypoalbuminemia reaching a nadir of 1.0-1.5 g/dL, malnutrition, iron-deficiency anemia, and deep-vein thrombosis. Colonoscopy and imaging revealed dense pseudopolyps from the proximal sigmoid to the cecum, with minimal inflammation. Renal and hepatic causes of protein loss were excluded through routine urinalysis, the absence of proteinuria, normal creatinine levels, normal liver enzymes, and unremarkable renal and hepatic imaging. Although formal quantitative PLE testing, such as α-1 antitrypsin clearance, was unavailable at our center, the persistent severe hypoalbuminemia, minimal inflammatory activity, and exclusion of alternative etiologies strongly supported a diagnosis of pseudopolyposis-associated PLE. Management included multiple biologics, steroid tapering, total parenteral nutrition, and anticoagulation; colectomy was declined. Clinicians should maintain a high index of suspicion for PLE in UC patients with extensive pseudopolyposis and hypoalbuminemia disproportionate to the degree of inflammation.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Nephrotic Syndrome I : Introduction

